arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

SATURDAY 9 OCTOBER 2021

Saturday 09 Oct

Plenary Session 2 The great wall of Fungi

Chairs: Carol Munro, UK & Julian Naglik, UK

08:30

PS2.1 Immune recognition of fungi: the writing on the wall

Neil Gow, UK, FECMM

09:00

PS2.2 Aspergillus cell wall

Top 10 papers

09:30

Clinical / diagnostics / treatment

Don Sheppard, USA, FECMM

09:30

Basic / immunology / genomics

Julian Naglik, UK, FECMM & Agostinho Carvalho, Portugal, FECMM

Quiz the expert sessions

10:15

Q01 PCR based diagnosis of invasive mold infection

Maurizio Sanguinetti, Italy & Sean Zhang , USA

10:15

Q02 Recurrent Vulvovaginal Candidiasis (VVC)

Riina Richardson, UK, FECMM

10:15

Q03 Clinical Mycology- How to get things going in LMICs

Rita Oladele, Nigeria, FECMM & Bright Ocansey, UK

10:15

Q04 Management of candida in the ICU

Luis Ostrosky-Zeichner, USA, FECMM

10:15

Q05 Mamangement stragegy in hematology

Marcio Nucci, Brazil, FECMM & Johan Maertens, Belgium, FECMM

10:15

Q06 Teaching Medical Mycology

Ester Segal, Israel, FECMM & June Kwon-Chung, USA

11:00

Poster session

12:00

Lunch break

12:30

Sponsored Integrated Symposium 2

More information on https://www.timm2021.org/sponsored-symposia/

14:15

Parallel Symposia 5-9

Symposium 5 Dermatophytes and fungal skin infections

Chairs: Sevtap Arikan Akdagli, Turkey, FECMM& Arunaloke Chakrabarti, India, FECMM

14:15

S05.1 Global epidemiology: What is changing, what is remarkable?

Rudramurthy Shivaprakash, India, FECMM

14:35

S05.2 How to determine MICs for my dermatophyte strain: Protocoles, tips, and trics

Sevtap Arikan Akdagli, Turkey, FECMM

14:55

S05.3 Primary immunodeficiencies and dermatophytoses: What else do we know?

Fanny Lanternier, France, FECMM

15:15

S05.4 Malassezia: epidemiology and host-response studies’

Dora Corzo-Leon, Scotland

Symposium 6 Immunity to fungi

Chairs: Agostinho Carvalho, Portugal, FECMM & Rebecca Drummond, UK

14:15

S06.1 Macrophage metabolism during Candida infection

Rebecca Drummond, UK

14:35

S06.2 Immuno genetics

Anna Puel, France

Symposium 7 Prophylaxis of Invasive Fungal Infections in Solid Organ Transplant Recipients

Chairs: Shahid Husain, Canada, FECMM

14:15

S07.1 Alternatives to drug treatment

Mihai Netea, the Netherlands

14:35

S07.2 Antifungal prophylaxis: Who, with what and how long?

Shmuel Shoham, USA

14:55

S07.3 Epidemiology

Shahid Husain, Canada, FECMM

Symposium 8 Update on diagnosis and treatment of chronic pulmonary aspergillosis (CPA)

Chairs: Aleksandra Barac, Serbia, FECMM

14:15

S08.1 Diagnostic Value of Galactomannan in Bronchoalveolar Lavage Fluid for Chronic Respiratory Disease with Pulmonary Aspergillosis

Aleksandra Barac, Serbia, FECMM

14:35

S08.2 Underlying Conditions and Clinical Spectrum of Chronic Pulmonary Aspergillosis (CPA)

14:55

S08.3 Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis

Felix Bogomin, Uganda, FECMM

Symposium 9 Latest results of ECMM and international registries

Chair: Tamas Papp, Hungary

14:15

S09.1 Chief-Net

Yao Wang

14:30

S09.2 CPAnet

Eva van Braeckel, NL

14:45

S09.3 FungiNOS

Nina Khanna, CH

15:00

S09.4 CandiReg

Philipp Köhler, FECMM, DE

15:15

S09.5 Epidemiology of Candida glabrata resistance in France and Germany within the frame of the ARest consortium

Alexandre Alanio, FR

15:30

S09.6 FungiScope

15:45

Coffee break

16:15

Parallel Symposia 10-13

Symposium 10 Candida and other yeast infections

Chairs: Malcolm Richardson, UK, FECMM & Cornelia Lass Florl, Austria, FECMM

16:15

S10.1 Diagnosis of candida: Culture, BDG and Mannan

Liz Johnson, UK

16:35

S10.2 The role of PCR and T2 MR

Cornelia Lass Florl, Austria, FECMM

16:55

S10.3 Mixed Yeast infections - Common or not?

Ana Alastruey-Izquierdo, Spain, FECMM

17:15

S10.4 Epidemiology and Clinical Burden of Candida infections across Europe - Results of ECMM Candida III

Maiken Arendrup, Denmark

Symposium 11 The Myc(icr)obiome and Fungal Infections

Chairs: Anne Puel, France & Ilse Jacobsen, Germany

16:15

S11.1 The Lung mycobiom in health and disease

Paul Bowyer, UK

16:35

S11.2. Epidemiology of Fungal Infection in the ICU: Viral Infection a relevant risk factor?

Matteo Bassetti, Italy

16:55

S11.3 Mycobiome and invasive candidiasis

Tobias Hohl, USA, FECMM

17:15

S11.4 Mycobiome and microbial interactions

Ilse Jacobsen, Germany

Symposium 12 Viral infections and fungal disease

16:15

S12.1 Immunology

Frank van de Veerdonk, the Netherlands

16:35

S12.2 Definition, Diagnosis and Treatment of COVID-19 associated pulmonary aspergillosis- ECMM/ISHAM Consensus Guidance

Philipp Köhler, Germany, FECMM

16:55

S12.3 CMV

Arunaloke Chakrabarti, India, FECMM

Symposium 13 Emerging fungal issues

Chair: Anuradha Chowdhary, India, FECMM & Suzana Hadina, Hungary

16:15

S13.1 Emergomyces

Nelesh Govender, South Africa, FECMM

16:35

S13.2 Emerging rare yeasts in outbreaks

Anuradha Chowdhary, India, FECMM

16:55

S13.3 antifungal resistance

Matthew Fisher, UK, FECMM

18:00

Sponsored Integrated Symposium 3

More information on www.timm2021.org/sponsored-symposia

19:30

Sponsored reception